Eytan Wine, Jennifer deBruyn, Eileen Crowley, Anne M Griffiths
{"title":"加拿大儿童炎症性肠病网络对美国食品和药物管理局关于儿科炎症性肠病:开发治疗药物的行业指南草案的回应。","authors":"Eytan Wine, Jennifer deBruyn, Eileen Crowley, Anne M Griffiths","doi":"10.1093/jcag/gwae034","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17263,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":"7 6","pages":"397-398"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11637986/pdf/","citationCount":"0","resultStr":"{\"title\":\"Response from the Canadian Children Inflammatory Bowel Disease Network to the US Food and Drug Administration Draft Guidance for Industry on pediatric inflammatory bowel disease: developing drugs for treatment.\",\"authors\":\"Eytan Wine, Jennifer deBruyn, Eileen Crowley, Anne M Griffiths\",\"doi\":\"10.1093/jcag/gwae034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17263,\"journal\":{\"name\":\"Journal of the Canadian Association of Gastroenterology\",\"volume\":\"7 6\",\"pages\":\"397-398\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11637986/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Canadian Association of Gastroenterology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/jcag/gwae034\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Canadian Association of Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jcag/gwae034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Response from the Canadian Children Inflammatory Bowel Disease Network to the US Food and Drug Administration Draft Guidance for Industry on pediatric inflammatory bowel disease: developing drugs for treatment.